ArticleDrug design, development and therapy2021

A Novel Bispecific Immunotoxin Delivered by Human Bone Marrow-Derived Mesenchymal Stem Cells to Target Blood Vessels and Vasculogenic Mimicry of Malignant Gliomas [Retraction].

No numbers read from the abstract.

Not cited yet